Institutional Career Development Core
Institutional Career Development Core
批准号:
10524302
负责人:
John K. Amory
金额:
$137.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-06-01 至 2027-02-28
关键词:
AlaskaAwardChildClinicalClinical ResearchCommunitiesCompetenceComplexDisciplineDiseaseDoctor of PhilosophyEducational CurriculumEnvironmentEthnic OriginFacultyFred Hutchinson Cancer Research CenterFundingGoalsHealthHumanIdahoInstitutesLeadMentorsMentorshipMontanaPositioning AttributePreventive measureProgram DevelopmentPublicationsRaceResearchResearch PersonnelRural HealthScientistTalentsTimeTrainingTranslational ResearchUnderserved PopulationUnited States National Institutes of HealthUniversitiesWagesWashingtonWorkWyomingbasebehavioral/social sciencecareercareer developmentcohortcollaborative environmentdisabilityearly-career facultyexperienceimprovedinnovationinvestigator trainingmultidisciplinarynext generationnoveloutreachpeerprogramsrecruitrural arearural underservedsocialsocial disadvantagetranslational health sciencetranslational scientist
中文摘要
联系PD/PI:Disis,Mary L.Inst-Career-Dev-001(378)
鉴于开发预防措施和新的疾病治疗方法以及
为了改善健康,我们认为必须培训下一代翻译研究人员
跨学科环境。翻译健康科学研究所(IIHS)--
华盛顿大学西雅图儿童中心和弗雷德·哈钦森癌症研究中心-是一个令人难以置信的
丰富的临床和转化性研究环境,吸引博士、医学博士和其他受过临床培训的人
调查人员。Iths的覆盖范围从西雅图的枢纽延伸到华盛顿、怀俄明州、阿拉斯加、
蒙大拿州和爱达荷州(WWAMI),提供独特的机会,特别是在农村卫生和卫生领域
通过临床研究网络和合作大学,服务不足的人群。自2007年以来,伊思
KL2多学科职业发展计划培养了一批来自世界各地的有才华的初级教师
各式各样的学科。这个为期3年的项目的主要目标是培养一批不同的早期职业教师。
领导跨学科团队进行翻译研究,最终改善人类健康。Iths
每年为9名学者提供工资和研究资金、保护时间和指导。62位学者
到目前为止,培训期间出版了458份出版物,并在NIH获得了7300多万美元的奖励
资金问题。信息与通信技术研究所现在提议通过两个新的主要目标来加强现有的KL2方案:
1.创建一个更大、更具包容性的队列,通过增加一个
机构支持的KL2研讨会研究员计划。我们每年将保留13-15名研讨会研究员,
全面参与KL2课程长达2年但得到以下支持的早期职业调查人员
其他基金。更大的队列将通过为获得资助的学者提供更多
为同行参与提供机会,并增加更多不同的研究视角,以及来自
不同的文化和社会背景,对创新产生积极影响。
2.增加KL2群体的多样性,以支持更多来自代表性不足的科学家
基于种族/族裔、残疾和社会劣势的背景以及来自区域的背景
研究机构。我们将扩大外展、有针对性的招聘和应用前支持,以
从西雅图的3个合作伙伴以外吸引更多的调查人员,并从已确定的团体中吸引更多的调查人员
美国国立卫生研究院在生物医学、临床、行为和社会科学方面的代表性不足。以这一专业为中心
AIM将帮助我们建立一支更加多元化的翻译研究队伍。
KL2学者和研讨会研究员将使用以翻译科学为基础的课程进行严格的培训
在独特的跨学科环境中的核心能力。学者们受益于他们的科学指导
导师和KL2计划总监。毕业生将被定位为领导有效的研究团队
跨越学科界限,对人类健康产生积极影响,并影响到一系列社区。
英文摘要
Contact PD/PI: Disis, Mary L. Inst-Career-Dev-001 (378)
Given the complex challenges of developing preventative measures and novel treatments for disease and
improving health, we see an imperative to train the next generation of translational researchers in an
interdisciplinary environment. The Institute of Translational Health Sciences (ITHS)—a partnership between the
University of Washington, Seattle Children's, and Fred Hutchinson Cancer Research Center—is an incredibly
rich environment for clinical and translational research and attracts PhD, MD and other clinically trained
investigators. The reach of ITHS extends beyond its hub in Seattle across Washington, Wyoming, Alaska,
Montana, and Idaho (WWAMI), providing distinct opportunities, particularly in the areas of rural health and
underserved populations, through clinical research networks and collaborating universities. Since 2007, the ITHS
KL2 Multidisciplinary Career Development Program has cultivated a group of talented junior faculty from a wide
variety of disciplines. The primary goal of the 3-year program is to prepare a diverse group of early career faculty
to lead interdisciplinary teams conducting translational research that will ultimately improve human health. ITHS
provides salary and research funds, protected time, and mentorship to 9 scholars each year. The 62 scholars
trained to date produced 458 publications while in the program and have been awarded more than $73M in NIH
funding. ITHS now proposes to enhance the existing KL2 program through two new major aims to:
1. Create a larger, more inclusive cohort to promote scholar engagement through the addition of an
institutionally supported KL2 seminar fellows program. We will maintain 13-15 seminar fellows per year,
early career investigators who participate fully in the KL2 curriculum for up to 2 years but are supported by
other funds. The larger cohort will enrich the KL2 experience for funded scholars by providing more
opportunities for peer engagement and adding more diverse research perspectives, as well as those from
different cultural and social backgrounds, which have a positive impact on innovation.
2. Increase the diversity of the KL2 cohort to support more scientists from underrepresented
backgrounds on the basis of race/ethnicity, disability, and social disadvantage, and from regional
research organizations. We will expand outreach, purposeful recruitment, and pre-application support to
draw more investigators from outside the 3 Seattle-based partners and investigators from groups identified
by NIH as underrepresented in biomedical, clinical, behavioral, and social sciences. Centering this as a major
aim will help us create a more diverse translational research workforce.
KL2 scholars and seminar fellows will be rigorously trained using a curriculum grounded in translational science
core competencies in a unique interdisciplinary environment. Scholars benefit from guidance of their scientific
mentors and KL2 Program Directors. Graduates will be positioned to lead effective research teams that work
across disciplinary boundaries, making a positive impact on human health, and reaching a range of communities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALDH1A1/A2 Inhibitors for Male Contraception
-
批准号:10430041
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2019
-
负责人:John K. Amory
-
依托单位:
ALDH1A1/A2 Inhibitors for Male Contraception
-
批准号:10172963
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2019
-
负责人:John K. Amory
-
依托单位:
ALDH1A1/A2 Inhibitors for Male Contraception
-
批准号:10651653
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2019
-
负责人:John K. Amory
-
依托单位:
ALDH1A1/A2 Inhibitors for Male Contraception
-
批准号:10020794
-
项目类别:
-
资助金额:$38.26万
-
财政年份:2019
-
负责人:John K. Amory
-
依托单位:
Institutional Career Development Core
-
批准号:10731946
-
项目类别:
-
资助金额:$18.22万
-
财政年份:2017
-
负责人:John K. Amory
-
依托单位:
Institutional Career Development Core
-
批准号:10711974
-
项目类别:
-
资助金额:$13.56万
-
财政年份:2017
-
负责人:John K. Amory
-
依托单位:
Institutional Career Development Core
-
批准号:10595040
-
项目类别:
-
资助金额:$122.65万
-
财政年份:2017
-
负责人:John K. Amory
-
依托单位:
Institute of Translational Health Sciences
-
批准号:9474336
-
项目类别:
-
资助金额:$133.06万
-
财政年份:2017
-
负责人:John K. Amory
-
依托单位:
Retinoic Acid in Male Infertility
-
批准号:9230783
-
项目类别:
-
资助金额:$12.75万
-
财政年份:2015
-
负责人:John K. Amory
-
依托单位:
BDADs for Male Contraception
-
批准号:8049190
-
项目类别:
-
资助金额:$26.79万
-
财政年份:2009
-
负责人:John K. Amory
-
依托单位:
BDADs for Male Contraception
-
批准号:8427375
-
项目类别:
-
资助金额:$25.61万
-
财政年份:2009
-
负责人:John K. Amory
-
依托单位:
BDADs for Male Contraception
-
批准号:7770803
-
项目类别:
-
资助金额:$26.84万
-
财政年份:2009
-
负责人:John K. Amory
-
依托单位:
BDADs for Male Contraception
-
批准号:7863969
-
项目类别:
-
资助金额:$0.53万
-
财政年份:2009
-
负责人:John K. Amory
-
依托单位:
BDADs for Male Contraception
-
批准号:8230760
-
项目类别:
-
资助金额:$26.52万
-
财政年份:2009
-
负责人:John K. Amory
-
依托单位:
BDADs for Male Contraception
-
批准号:7626135
-
项目类别:
-
资助金额:$28.5万
-
财政年份:2009
-
负责人:John K. Amory
-
依托单位:
Oral Testosterone for Male Hormonal Contraception
-
批准号:7284591
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2007
-
负责人:John K. Amory
-
依托单位:
ORAL ANDROGENS IN MAN-3: PK OF ORAL TESTOSTERONE BY ALPHA5-DUTASTERIDE
-
批准号:7603473
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2007
-
负责人:John K. Amory
-
依托单位:
ORAL ANDROGENS IN MAN-4: GONADOTROPIN SUPPRESSION
-
批准号:7603511
-
项目类别:
-
资助金额:$0.49万
-
财政年份:2007
-
负责人:John K. Amory
-
依托单位:
ORAL ANDROGENS IN MAN-3: PK OF ORAL TESTOSTERONE BY ALPHA5-DUTASTERIDE
-
批准号:7379372
-
项目类别:
-
资助金额:$8.85万
-
财政年份:2006
-
负责人:John K. Amory
-
依托单位:
ORAL ANDROGENS IN MAN-2: PK OF ORAL TESTOSTERONE WITH 5 -REDUCTASE
-
批准号:7198860
-
项目类别:
-
资助金额:$7.42万
-
财政年份:2005
-
负责人:John K. Amory
-
依托单位:
海外基金